Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Medzyme Invest Öresund AB
AB
Active
Org 5568488505
Lantvägen 44, 246 33
Löddeköpinge
Other financial service activities, except insurance and pension funding n.e.c.
· NACE 6499
Est. 2011
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Medzyme Invest Öresund AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
−16
−18
−0
—
EBITDA
−165
−172
−122
−21
−18
Depreciation & amort.
−0
—
—
—
—
EBIT
−165
−172
−122
−21
−18
Net financials
384
598
70
190
184
Profit before tax
218
427
−52
169
167
Tax
−0
—
—
—
—
Net profit
218
427
−52
169
167
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
2 917
3 103
2 810
2 133
1 844
Equity
2 764
3 003
2 756
2 126
1 792
Long-term debt
0
—
—
—
—
Short-term debt
153
100
53
7
51
Total debt
153
100
53
7
51
Financial ratios
5-year trend
EBITDA margin
-1765200.0%
This company
15.8%
Market median
-11172252% vs market
2021
2025
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
2021
2025
Return on equity
9.3%
This company
18.4%
Market median
-49% vs market
2021
2025
Net profit margin
16670200.0%
This company
8.1%
Market median
+205804838% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Medzyme Invest Öresund AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
